Keros Therapeutics Inc
Biotechnology
Healthcare
KROS
41.02 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
15.81
52 week high
70.00
high
15.99
52 week low
0.00
low
15.65
growth
-71.88 %
previous Close
15.90
P/E ratio
market cap
584 M
div yield
0
net profit margin
0.00 %
-70.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top